Cytovia Therapeutics
再凌生物
Cytovia Therapeutics
Biotech/Healthcare
Cytovia Therapeutics aims to accelerate patient access to transformative cell therapies and immunotherapies, addressing several of the most challenging unmet medical needs in cancer. Cytovia focuses on natural killer (NK) cell biology and applies precision engineering to induced pluripotent stem…
Latest round: Angel (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.